Docetaxel induction therapy in locally advanced squamous cell carcinoma of the head and neck

Patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) are often treated with induction chemotherapy or chemoradiotherapy, but to date without major impact on survival. The combination of cisplatin–5-fluorouracil (5-FU) (PF) has been used as standard induction therapy; h...

Descripción completa

Detalles Bibliográficos
Autores principales: Posner, M R, Lefebvre, J L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376785/
https://www.ncbi.nlm.nih.gov/pubmed/12556952
http://dx.doi.org/10.1038/sj.bjc.6600685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376785/
https://www.ncbi.nlm.nih.gov/pubmed/12556952
http://dx.doi.org/10.1038/sj.bjc.6600685

Ejemplares similares